Precision Medicine Market Research Report: By Type (Therapeutics, Diagnostics, Personalized Medical Care) - Global Industry Analysis and Growth Forecast to 2030

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Type

1.3.2 Market Segmentation by Region

1.3.3 Analysis Period

1.3.4 Market Data Reporting Unit

1.3.4.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Type

4.1.1.1 Therapeutics

4.1.1.2 Diagnostics

4.1.1.2.1 Esoteric lab services

4.1.1.2.2 Esoteric tests

4.1.1.2.3 Molecular diagnostics

4.1.1.3 Personalized medical care

4.1.1.3.1 EMR

4.1.1.3.2 Telemedicine

4.1.1.3.2.1 By service

4.1.1.3.2.1.1 Tele consulting

4.1.1.3.2.1.2 Tele monitoring

4.1.1.3.2.1.3 Tele education

4.1.1.3.2.1.4 Tele training

4.1.1.3.2.1.5 Others

4.1.1.3.2.2 By specialty

4.1.1.3.2.2.1 Dermatology

4.1.1.3.2.2.2 Gynecology

4.1.1.3.2.2.3 Cardiology

4.1.1.3.2.2.4 Neurology

4.1.1.3.2.2.5 Orthopedics

4.1.1.3.2.2.6 Others

4.1.1.3.3 DM

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing number of clinical trials for precision medicine

4.2.2 Drivers

4.2.2.1 Increasing government support

4.2.2.2 Rising number of approved personalized medicine

4.2.2.3 Growing medical tourism industry

4.2.2.4 Surging use of AI in precision medicine

4.2.2.5 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High cost for developing a precision medicine

4.2.3.2 Reimbursement policies

4.2.3.3 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Companies across APAC are showing interest toward the development of new precision medicine

4.3 Impact of COVID-19

4.3.1 Supply Side Analysis

4.3.1.1 Current scenario of major key players offerings precision medicines

4.3.1.2 Situation of lockdown and workforce availability

4.3.1.3 Production scenario

4.3.1.4 Situation of major countries supplying precision medicines

4.3.2 Demand Side Analysis

4.4 Porter’s Five Forces Analysis

4.4.1 Bargaining Power of Suppliers

4.4.2 Bargaining Power of Buyers

4.4.3 Intensity of Rivalry

4.4.4 Threat of New Entrants

4.4.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

5.1 By Type

5.1.1 Precision Medicine Diagnostics Market, by Type

5.1.2 Personalized Medical Care Market, by Type

5.1.2.1 Telemedicine market, by service

5.1.2.2 Telemedicine market, by specialty

5.2 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Type

6.1.1 Precision Medicine Diagnostics Market, by Type

6.1.2 Personalized Medical Care Market, by Type

6.1.2.1 Telemedicine market, by service

6.1.2.2 Telemedicine market, by specialty

6.2 By Country

6.2.1 U.S. Precision Medicine Market

6.2.1.1 By type

6.2.1.1.1 Precision medicine diagnostics market, by type

6.2.1.1.2 Personalized medical care market, by type

6.2.1.1.2.1 Telemedicine market, by service

6.2.1.1.2.2 Telemedicine market, by specialty

6.2.2 Canada Precision Medicine Market

6.2.2.1 By type

6.2.2.1.1 Precision medicine diagnostics market, by type

6.2.2.1.2 Personalized medical care market, by type

6.2.2.1.2.1 Telemedicine market, by service

6.2.2.1.2.2 Telemedicine market, by specialty

Chapter 7. Europe Market Size and Forecast

7.1 By Type

7.1.1 Precision Medicine Diagnostics Market, by Type

7.1.2 Personalized Medical Care Market, by Type

7.1.2.1 Telemedicine market, by service

7.1.2.2 Telemedicine market, by specialty

7.2 By Country

7.2.1 Germany Precision Medicine Market

7.2.1.1 By type

7.2.1.1.1 Precision medicine diagnostics market, by type

7.2.1.1.2 Personalized medical care market, by type

7.2.1.1.2.1 Telemedicine market, by service

7.2.1.1.2.2 Telemedicine market, by specialty

7.2.2 France Precision Medicine Market

7.2.2.1 By type

7.2.2.1.1 Precision medicine diagnostics market, by type

7.2.2.1.2 Personalized medical care market, by type

7.2.2.1.2.1 Telemedicine market, by service

7.2.2.1.2.2 Telemedicine market, by specialty

7.2.3 U.K. Precision Medicine Market

7.2.3.1 By type

7.2.3.1.1 Precision medicine diagnostics market, by type

7.2.3.1.2 Personalized medical care market, by type

7.2.3.1.2.1 Telemedicine market, by service

7.2.3.1.2.2 Telemedicine market, by specialty

7.2.4 Italy Precision Medicine Market

7.2.4.1 By type

7.2.4.1.1 Precision medicine diagnostics market, by type

7.2.4.1.2 Personalized medical care market, by type

7.2.4.1.2.1 Telemedicine market, by service

7.2.4.1.2.2 Telemedicine market, by specialty

7.2.5 Spain Precision Medicine Market

7.2.5.1 By type

7.2.5.1.1 Precision medicine diagnostics market, by type

7.2.5.1.2 Personalized medical care market, by type

7.2.5.1.2.1 Telemedicine market, by service

7.2.5.1.2.2 Telemedicine market, by specialty

Chapter 8. APAC Market Size and Forecast

8.1 By Type

8.1.1 Precision Medicine Diagnostics Market, by Type

8.1.2 Personalized Medical Care Market, by Type

8.1.2.1 Telemedicine market, by service

8.1.2.2 Telemedicine market, by specialty

8.2 By Country

8.2.1 Japan Precision Medicine Market

8.2.1.1 By type

8.2.1.1.1 Precision medicine diagnostics market, by type

8.2.1.1.2 Personalized medical care market, by type

8.2.1.1.2.1 Telemedicine market, by service

8.2.1.1.2.2 Telemedicine market, by specialty

8.2.2 China Precision Medicine Market

8.2.2.1 By type

8.2.2.1.1 Precision medicine diagnostics market, by type

8.2.2.1.2 Personalized medical care market, by type

8.2.2.1.2.1 Telemedicine market, by service

8.2.2.1.2.2 Telemedicine market, by specialty

8.2.3 India Precision Medicine Market

8.2.3.1 By type

8.2.3.1.1 Precision medicine diagnostics market, by type

8.2.3.1.2 Personalized medical care market, by type

8.2.3.1.2.1 Telemedicine market, by service

8.2.3.1.2.2 Telemedicine market, by specialty

Chapter 9. LATAM Market Size and Forecast

9.1 By Type

9.1.1 Precision Medicine Diagnostics Market, by Type

9.1.2 Personalized Medical Care Market, by Type

9.1.2.1 Telemedicine market, by service

9.1.2.2 Telemedicine market, by specialty

9.2 By Country

Chapter 10. MEA Market Size and Forecast

10.1 By Type

10.1.1 Precision Medicine Diagnostics Market, by Type

10.1.2 Personalized Medical Care Market, by Type

10.1.2.1 Telemedicine market, by service

10.1.2.2 Telemedicine market, by specialty

10.2 By Country

Chapter 11. Competitive Landscape

11.1 Product Benchmarking of Key Players

11.2 Strategic Developments of Key Players

11.2.1 Product Launches and Approvals

11.2.2 Partnerships and Collaborations

11.2.3 Others

Chapter 12. Company Profiles

12.1 Myriad Genetics Inc.

12.1.1 Business Overview

12.1.2 Product and Service Offerings

12.1.3 Key Financial Summary

12.2 Pacific Biosciences of California Inc.

12.2.1 Business Overview

12.2.2 Key Financial Summary

12.3 Partek Inc.

12.3.1 Business Overview

12.4 Randox Laboratories Ltd.

12.4.1 Business Overview

12.4.2 Product and Service Offerings

12.5 Menarini Silicon Biosystems S.p.a.

12.5.1 Business Overview

12.5.2 Product and Service Offerings

12.6 Oracle Corporation

12.6.1 Business Overview

12.6.2 Product and Service Offerings

12.6.3 Key Financial Summary

12.7 23andMe Inc.

12.7.1 Business Overview

12.7.2 Product and Service Offerings

12.8 Precision BioLogic Incorporated

12.8.1 Business Overview

12.8.2 Product and Service Offerings

12.9 EPIC SCIENCES INC.

12.9.1 Business Overview

12.9.2 Product and Service Offerings

12.10 Intomics

12.10.1 Business Overview

12.10.2 Product and Service Offerings

12.11 MDxHealth SA

12.11.1 Business Overview

12.11.2 Product and Service Offerings

12.11.3 Key Financial Summary

12.12 Asuragen Inc.

12.12.1 Business Overview

12.12.2 Product and Service Offerings

12.13 Almac Group Limited

12.13.1 Business Overview

12.13.2 Product and Service Offerings

12.14 International Business Machines Corporation

12.14.1 Business Overview

12.14.2 Product and Service Offerings

12.14.3 Key Financial Summary

12.15 Bristol-Myers Squibb Company

12.15.1 Business Overview

12.15.2 Product and Service Offerings

12.15.3 Key Financial Summary

12.16 Johnson & Johnson

12.16.1 Business Overview

12.16.2 Product and Service Offerings

12.16.3 Key Financial Summary

12.17 Eli Lilly and Company

12.17.1 Business Overview

12.17.2 Product and Service Offerings

12.17.3 Key Financial Summary

12.18 Sanofi

12.18.1 Business Overview

12.18.2 Product and Service Offerings

12.18.3 Key Financial Summary

12.19 Abbott Laboratories

12.19.1 Business Overview

12.19.2 Product and Service Offerings

12.19.3 Key Financial Summary

12.20 Bio-Rad Laboratories Inc.

12.20.1 Business Overview

12.20.2 Product and Service Offerings

12.20.3 Key Financial Summary

12.21 Danaher Corporation

12.21.1 Business Overview

12.21.2 Product and Service Offerings

12.21.3 Key Financial Summary

12.22 F. Hoffmann-La Roche Ltd.

12.22.1 Business Overview

12.22.2 Product and Service Offerings

12.22.3 Key Financial Summary

12.23 bioMérieux S.A.

12.23.1 Business Overview

12.23.2 Product and Service Offerings

12.23.3 Key Financial Summary

12.24 General Electric Company

12.24.1 Business Overview

12.24.2 Product and Service Offerings

12.24.3 Key Financial Summary

12.25 Thermo Fisher Scientific Inc.

12.25.1 Business Overview

12.25.2 Product and Service Offerings

12.25.3 Key Financial Summary

Chapter 13. Appendix

13.1 Abbreviations

11.16 Sources and References

13.2 Related Reports

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RETRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL PRECISION MEDICINE MARKET, BY TYPE, $B (2014–2019)

TABLE 5 GLOBAL PRECISION MEDICINE MARKET, BY TYPE, $B (2020–2030)

TABLE 6 GLOBAL PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $B (2014–2019)

TABLE 7 GLOBAL PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $B (2020–2030)

TABLE 8 GLOBAL PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $B (2014–2019)

TABLE 9 GLOBAL PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $B (2020–2030)

TABLE 10 GLOBAL TELEMEDICINE MARKET, BY SERVICE, $B (2014–2019)

TABLE 11 GLOBAL TELEMEDICINE MARKET, BY SERVICE, $B (2020–2030)

TABLE 12 GLOBAL TELEMEDICINE MARKET, BY SPECIALTY, $B (2014–2019)

TABLE 13 GLOBAL TELEMEDICINE MARKET, BY SPECIALTY, $B (2020–2030)

TABLE 14 GLOBAL PRECISION MEDICINE MARKET, BY REGION, $B (2014–2019)

TABLE 15 GLOBAL PRECISION MEDICINE MARKET, BY REGION, $B (2020–2030)

TABLE 16 NORTH AMERICA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 17 NORTH AMERICA PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 18 NORTH AMERICA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 19 NORTH AMERICA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 20 NORTH AMERICA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 21 NORTH AMERICA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 22 NORTH AMERICA TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 23 NORTH AMERICA TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 24 NORTH AMERICA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 25 NORTH AMERICA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 26 NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2019)

TABLE 27 NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020–2030)

TABLE 28 U.S. PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 29 U.S. PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 30 U.S. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 31 U.S. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 32 U.S. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 33 U.S. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 34 U.S. TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 35 U.S. TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 36 U.S. TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 37 U.S. TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 38 CANADA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 39 CANADA PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 40 CANADA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 41 CANADA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 42 CANADA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 43 CANADA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 44 CANADA TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 45 CANADA TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 46 CANADA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 47 CANADA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 48 EUROPE PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 49 EUROPE PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 50 EUROPE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 51 EUROPE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 52 EUROPE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 53 EUROPE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 54 EUROPE TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 55 EUROPE TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 56 EUROPE TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 57 EUROPE TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 58 EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2019)

TABLE 59 EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020–2030)

TABLE 60 GERMANY PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 61 GERMANY PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 62 GERMANY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 63 GERMANY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 64 GERMANY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 65 GERMANY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 66 GERMANY TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 67 GERMANY TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 68 GERMANY TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 69 GERMANY TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 70 FRANCE PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 71 FRANCE PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 72 FRANCE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 73 FRANCE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 74 FRANCE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 75 FRANCE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 76 FRANCE TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 77 FRANCE TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 78 FRANCE TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 79 FRANCE TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 80 U.K. PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 81 U.K. PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 82 U.K. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 83 U.K. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 84 U.K. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 85 U.K. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 86 U.K. TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 87 U.K. TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 88 U.K. TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 89 U.K. TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 90 ITALY PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 91 ITALY PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 92 ITALY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 93 ITALY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 94 ITALY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 95 ITALY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 96 ITALY TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 97 ITALY TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 98 ITALY TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 99 ITALY TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 100 SPAIN PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 101 SPAIN PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 102 SPAIN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 103 SPAIN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 104 SPAIN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 105 SPAIN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 106 SPAIN TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 107 SPAIN TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 108 SPAIN TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 109 SPAIN TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 110 APAC PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 111 APAC PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 112 APAC PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 113 APAC PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 114 APAC PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 115 APAC PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 116 APAC TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 117 APAC TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 118 APAC TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 119 APAC TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 120 APAC PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2019)

TABLE 121 APAC PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020–2030)

TABLE 122 JAPAN PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 123 JAPAN PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 124 JAPAN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 125 JAPAN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 126 JAPAN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 127 JAPAN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 128 JAPAN TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 129 JAPAN TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 130 JAPAN TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 131 JAPAN TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 132 CHINA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 133 CHINA PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 134 CHINA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 135 CHINA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 136 CHINA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 137 CHINA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 138 CHINA TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 139 CHINA TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 140 CHINA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 141 CHINA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 142 INDIA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 143 INDIA PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 144 INDIA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 145 INDIA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 146 INDIA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 147 INDIA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 148 INDIA TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 149 INDIA TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 150 INDIA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 151 INDIA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 152 LATAM PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 153 LATAM PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 154 LATAM PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 155 LATAM PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 156 LATAM PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 157 LATAM PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 158 LATAM TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 159 LATAM TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 160 LATAM TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 161 LATAM TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 162 LATAM PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2019)

TABLE 163 LATAM PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020–2030)

TABLE 164 MEA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2019)

TABLE 165 MEA PRECISION MEDICINE MARKET, BY TYPE, $M (2020–2030)

TABLE 166 MEA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2019)

TABLE 167 MEA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020–2030)

TABLE 168 MEA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2019)

TABLE 169 MEA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020–2030)

TABLE 170 MEA TELEMEDICINE MARKET, BY SERVICE, $M (2014–2019)

TABLE 171 MEA TELEMEDICINE MARKET, BY SERVICE, $M (2020–2030)

TABLE 172 MEA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2019)

TABLE 173 MEA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020–2030)

TABLE 174 MEA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2019)

TABLE 175 MEA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020–2030)

TABLE 176 PRODUCT BENCHMARKING OF KEY PLAYERS

TABLE 177 MYRIAD GENETICS INC. – AT A GLANCE

TABLE 178 MYRIAD GENETICS INC. – KEY FINANCIAL SUMMARY

TABLE 179 PACIFIC BIOSCIENCES OF CALIFORNIA INC. – AT A GLANCE

TABLE 180 PACIFIC BIOSCIENCES OF CALIFORNIA INC. – KEY FINANCIAL SUMMARY

TABLE 181 PARTEK INC. – AT A GLANCE

TABLE 182 RANDOX LABORATORIES LTD. – AT A GLANCE

TABLE 183 MENARINI SILICON BIOSYSTEMS S.P.A. – AT A GLANCE

TABLE 184 ORACLE CORPORATION – AT A GLANCE

TABLE 185 ORACLE CORPORATION – KEY FINANCIAL SUMMARY

TABLE 186 23ANDME INC. – AT A GLANCE

TABLE 187 PRECISION BIOLOGIC INCORPORATED – AT A GLANCE

TABLE 188 EPIC SCIENCES INC. – AT A GLANCE

TABLE 189 INTOMICS – AT A GLANCE

TABLE 190 MDXHEALTH SA – AT A GLANCE

TABLE 191 TABLE 15 MDXHEALTHM SA – KEY FINANCIAL SUMMARY

TABLE 192 ASURAGEN INC. – AT A GLANCE

TABLE 193 ALMAC GROUP LIMITED – AT A GLANCE

TABLE 194 INTERNATIONAL BUSINESS MACHINES CORPORATION – AT A GLANCE

TABLE 195 INTERNATIONAL BUSINESS MACHINES CORPORATION – KEY FINANCIAL SUMMARY

TABLE 196 BRISTOL-MYERS SQUIBB COMPANY – AT A GLANCE

TABLE 197 BRISTOL-MYERS SQUIBB COMPANY – KEY FINANCIAL SUMMARY

TABLE 198 JOHNSON & JOHNSON – AT A GLANCE

TABLE 199 JOHNSON & JOHNSON – KEY FINANCIAL SUMMARY

TABLE 200 ELI LILLY AND COMPANY – AT A GLANCE

TABLE 201 ELI LILLY AND COMPANY – KEY FINANCIAL SUMMARY

TABLE 202 SANOFI – AT A GLANCE

TABLE 203 SANOFI – KEY FINANCIAL SUMMARY

TABLE 204 ABBOTT LABORATORIES – AT A GLANCE

TABLE 205 ABBOTT LABORATORIES – KEY FINANCIAL SUMMARY

TABLE 206 BIO-RAD LABORATORIES INC. – AT A GLANCE

TABLE 207 BIO-RAD LABORATORIES INC. – KEY FINANCIAL SUMMARY

TABLE 208 DANAHER CORPORATION – AT A GLANCE

TABLE 209 DANAHER CORPORATION – KEY FINANCIAL SUMMARY

TABLE 210 F. HOFFMANN-LA ROCHE LTD. – AT A GLANCE

TABLE 211 F. HOFFMANN-LA ROCHE LTD. – KEY FINANCIAL SUMMARY

TABLE 212 BIOMÉRIEUX S.A. – AT A GLANCE

TABLE 213 BIOMÉRIEUX S.A. – KEY FINANCIAL SUMMARY

TABLE 214 GENERAL ELECTRIC COMPANY – AT A GLANCE

TABLE 215 GENERAL ELECTRIC COMPANY – KEY FINANCIAL SUMMARY

TABLE 216 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 217 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY

 

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 GLOBAL PRECISION MEDICINE MARKET SUMMARY

FIG 8 NUMBER OF APPROVED PRECISION MEDICINE (2008–2016)

FIG 9 BARGAINING POWER OF SUPPLIERS

FIG 10 BARGAINING POWER OF BUYERS

FIG 11 INTENSITY OF RIVALRY

FIG 12 THREAT OF NEW ENTRANTS

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL PRECISION MEDICINE MARKET SNAPSHOT

FIG 15 GLOBAL PRECISION MEDICINE MARKET, BY TYPE, $B (2014–2030)

FIG 16 GLOBAL PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $B (2014–2030)

FIG 17 GLOBAL PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $B (2014–2030)

FIG 18 GLOBAL TELEMEDICINE MARKET, BY SERVICE, $B (2014–2030)

FIG 19 GLOBAL TELEMEDICINE MARKET, BY SPECIALTY, $B (2014–2030)

FIG 20 WORLDWIDE MAJOR MARKETS FOR PRECISION MEDICINE

FIG 21 NORTH AMERICA PRECISION MEDICINE MARKET SNAPSHOT

FIG 22 NORTH AMERICA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 23 NORTH AMERICA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 24 NORTH AMERICA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 25 NORTH AMERICA TELEMEDICINE MARKET, BY SERVICE, $M (2014–2030)

FIG 26 NORTH AMERICA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2030)

FIG 27 NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2030)

FIG 28 U.S. PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 29 U.S. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 30 U.S. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 31 CANADA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 32 CANADA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 33 CANADA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 34 EUROPE PRECISION MEDICINE MARKET SNAPSHOT

FIG 35 EUROPE PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 36 EUROPE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 37 EUROPE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 38 EUROPE TELEMEDICINE MARKET, BY SERVICE, $M (2014–2030)

FIG 39 EUROPE TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2030)

FIG 40 EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2030)

FIG 41 GERMANY PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 42 GERMANY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 43 GERMANY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 44 FRANCE PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 45 FRANCE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 46 FRANCE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 47 U.K. PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 48 U.K. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 49 U.K. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 50 ITALY PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 51 ITALY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 52 ITALY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 53 SPAIN PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 54 SPAIN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 55 SPAIN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 56 APAC PRECISION MEDICINE MARKET SNAPSHOT

FIG 57 APAC PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 58 APAC PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 59 APAC PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 60 APAC TELEMEDICINE MARKET, BY SERVICE, $M (2014–2030)

FIG 61 APAC TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2030)

FIG 62 APAC PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2030)

FIG 63 JAPAN PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 64 JAPAN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 65 JAPAN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 66 CHINA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 67 CHINA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 68 CHINA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 69 INDIA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 70 INDIA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 71 INDIA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 72 LATAM PRECISION MEDICINE MARKET SNAPSHOT

FIG 73 LATAM PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 74 LATAM PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 75 LATAM PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 76 LATAM TELEMEDICINE MARKET, BY SERVICE, $M (2014–2030)

FIG 77 LATAM TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2030)

FIG 78 LATAM PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2030)

FIG 79 MEA PRECISION MEDICINE MARKET SNAPSHOT

FIG 80 MEA PRECISION MEDICINE MARKET, BY TYPE, $M (2014–2030)

FIG 81 MEA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014–2030)

FIG 82 MEA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014–2030)

FIG 83 MEA TELEMEDICINE MARKET, BY SERVICE, $M (2014–2030)

FIG 84 MEA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014–2030)

FIG 85 MEA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014–2030)

FIG 86 MYRIAD GENETICS INC. – REVENUE SPLIT BY SEGMENT (2020)

FIG 87 PACIFIC BIOSCIENCES OF CALIFORNIA INC. – REVENUE SPLIT BY GEOGRAPHY (2019)

FIG 88 ORACLE CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)

FIG 89 MDXHEALTHM SA – REVENUE BY GEOGRAPHY (2019)

FIG 90 INTERNATIONAL BUSINESS MACHINES CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 91 BRISTOL-MYERS SQUIBB COMPANY – REVENUE SPLIT BY GEOGRAPHY (2019)

FIG 92 JOHNSON & JOHNSON – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 93 ELI LILLY AND COMPANY – REVENUE SPLIT BY THERAPEUTIC AREA AND GEOGRAPHY (2019)

FIG 94 SANOFI – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 95 ABBOTT LABORATORIES – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 96 BIO-RAD LABORATORIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 97 DANAHER CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 98 F. HOFFMANN-LA ROCHE LTD. – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)

FIG 99 BIOMÉRIEUX S.A. – REVENUE SPLIT BY APPLICATION AND GEOGRAPHY (2018)

FIG 100 GENERAL ELECTRIC COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 101 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)